Join the 4th virtual symposium on High Throughput Technology for Hit Generation!
Mestrelab is proud to sponsor the 4th Edelris Virtual Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery.
Join the Mestrelab talk, “An Affinity for Automation” given by our colleague Marcel Lachenmann, Senior Applications Scientist, on Wednesday, May 15, at 16:50 (CEST)
We look forward to this event and the valuable insights it will provide to researchers and professionals involved in drug discovery and development. Exciting news—registration is free!
When?
May 15-16, 2024
Where?
Discover How Affinity Screen Can Enhance Your Workflow and Boost Efficiency
- Streamlined Process: Affinity Screen automates every step from data pickup to processing, reporting, and archiving, reducing complexity and minimizing manual input.
- Efficient Hit Identification: Seamless review and confirmation of potential hits without sifting through irrelevant data saves time and effort.
- Customizable and Adaptable: Affinity Screen supports the implementation of user’s own methods or laboratory’s SOPs, providing flexibility and customization options.
- Accelerated Discovery: By removing the bottleneck of data processing and analysis, Affinity Screen speeds up the discovery of new hits. It can screen up to 11,000 compounds per plate in a single click, with the ability to scale up for more plates in a single run.
- Versatile Integration: Affinity Screen fits perfectly in a drug discovery environment, complementing other LC-MS analyses such as quantification and determination of physicochemical properties of hit molecules.